Current
Neuro-Oncology


Volume 22 Number 5
May 2020


Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 5, May


CONTENTS


CENTRAL NERVOUS SYSTEM TUMORS




GLIOMAS


HIGH-GRADE GLIOMAS


LOW-GRADE GLIOMAS




DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS


GLIOBLASTOMA


GLIOSARCOMA


EPITHELIOID GLIOBLASTOMA


DIFFUSE MIDLINE GLIOMA




EPENDYMAL TUMORS


EPENDYMOMA




TUMORS OF THE PINEAL REGION


PINEOCYTOMA




EMBRYONAL TUMORS


MEDULLOBLASTOMA


ATYPICAL THERATOID/RHABDOID TUMOR




MENINGIOMAS


MENINGIOMA




MESENCHIMAL NON-MENINGOTHELIAL TUMORS




METASTATIC TUMORS





CENTRAL NERVOUS SYSTEM TUMORS


Esmaeilzadeh M, Uksul N, Hong B, von Kaisenberg C, Scheinichen D, Lang JM, Hermann EJ, Hillemanns P, Krauss JK.
Intracranial emergencies during pregnancy requiring urgent neurosurgical treatment.
Clin Neurol Neurosurg. [2020 May 12]. 2020;195:105905. Doi 10.1016/j.clineuro.2020.105905. _




Schraw JM, Desrosiers TA, Nembhard WN, Langlois PH, Meyer RE, Canfield MA, Rasmussen SA, Chambers TM, Spector LG, Plon SE, Lupo PJ.
Cancer diagnostic profile in children with structural birth defects: An assessment in 15,000 childhood cancer cases.
Cancer. 2020 May 29. 2020;10.1002/cncr.32982. Doi 10.1002/cncr.32982. _




Smoll NR, Mathews JD, Scurrah KJ.
CT scans in childhood predict subsequent brain cancer: Finite mixture modelling can help separate reverse causation scans from those that may be causal.
Cancer Epidemiol. [2020 May 25]. 2020;67:101732. Doi 10.1016/j.canep.2020.101732. _




Talabaev M, Venegas K, Zabrodets G, Zmachinskaya V, Antonenko A, Naumenko D, Salauyeva H, Churyla N.
Result of awake surgery for pediatric eloquent brain area tumors: single-center experience.
Childs Nerv Syst. 2020 May 21. 2020;10.1007/s00381-020-04666-8. Doi 10.1007/s00381-020-04666-8. _



GLIOMAS


Brown DA, Hanalioglu S, Chaichana K, Duffau H.
Transcorticosubcortical Approach for Left Posterior Mediobasal Temporal Region Gliomas: A Case Series and Anatomic Review of Relevant White Matter Tracts.
World Neurosurg. [2020 Apr 29]. 2020;S1878-8750(20)30854-8. Doi 10.1016/j.wneu.2020.04.147. _




Capo G, Skrap M, Guarracino I, Isola M, Battistella C, Ius T, Tomasino B.
Cognitive Functions in Repeated Glioma Surgery.
Cancers (Basel). 2020 Apr 26. 2020;12(5):E1077. Doi 10.3390/cancers12051077. _




Fang S, Li Y, Wang Y, Zhang Z, Jiang T.
Awake craniotomy for gliomas involving motor-related areas: classification and function recovery.
J Neurooncol. [2020 Apr 29]. 2020;10.1007/s11060-020-03520-w. Doi 10.1007/s11060-020-03520-w. _




Malmir H, Shayanfar M, Mohammad-Shirazi M, Sharifi G, Esmaillzadeh A.
Legume and Nuts Consumption in Relation to Glioma: A Case- Control Study.
Nutr Cancer. [2020 May 14]. 2020;1-7. Doi 10.1080/01635581.2020.1766091. _




Li Z, Wu H, Wu B, Lyu J, Liu Y, Tang C, Hua W, Hu S, Wang Y, Zhang Y.
Long term follow-up and outcomes in adult patients with thalamic gliomas.
Clin Neurol Neurosurg. [2020 May 19]. 2020;195:105888. Doi 10.1016/j.clineuro.2020.105888. _




Liu S, Shah Z, Sav A, Russo C, Berkovsky S, Qian Y, Coiera E, Di Ieva A.
Isocitrate dehydrogenase (IDH) status prediction in histopathology images of gliomas using deep learning.
Sci Rep. 2020 May 7. 2020;10(1):7733. Doi 10.1038/s41598-020-64588-y. _




Mousavi SM, Rigi S, Shayanfar M, Mohammad-Shirazi M, Sharifi G, Esmaillzadeh A.
Refined grains consumption is associated with a greater odds of glioma.
Nutr Neurosci. [2020 May 7]. 2020;1‐9. Doi 10.1080/1028415X.2020.1758889. _




Ogawa T, Kawai N, Miyake K, Shinomiya A, Yamamoto Y, Nishiyama Y, Tamiya T.
Diagnostic value of PET/CT with 11C-methionine (MET) and 18F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification.
EJNMMI Res. 2020 May 7. 2020;10(1):44. Doi 10.1186/s13550-020-00633-1. _




Oliveira D, Stegmayr C, Heinzel A, Ermert J, Neumaier B, Shah NJ, Mottaghy FM, Langen KJ, Willuweit A.
High uptake of 68Ga-PSMA and 18F-DCFPyL in the peritumoral area of rat gliomas due to activated astrocytes.
EJNMMI Res. 2020 May 25. 2020;10(1):55. Doi 10.1186/s13550-020-00642-0. _




Shen S, Feng S, Liu H, Jiang J, Yu X.
Associations of histological and molecular alterations with invasion of the corpus callosum in gliomas.
Acta Neurochir (Wien). [2020 May 21]. 2020;10.1007/s00701-020-04376-9. Doi 10.1007/s00701-020-04376-9. _




Suárez-García JG, Hernández-López JM, Moreno-Barbosa E, de Celis-Alonso B.
A simple model for glioma grading based on texture analysis applied to conventional brain MRI.
PLoS One. 2020 May 15. 2020;15(5):e0228972. Doi 10.1371/journal.pone.0228972. _




Wang X, Li F, Wang D, Zeng Q.
Diffusion kurtosis imaging combined with molecular markers as a comprehensive approach to predict overall survival in patients with gliomas.
Eur J Radiol. [2020 Apr 23]. 2020;128:108985. Doi 10.1016/j.ejrad.2020.108985. _




Zhang L, Yang LQ, Wen L, Lv SQ, Hu JH, Li QR, Xu JP, Xu RF, Zhang D.
Noninvasively Evaluating the Grading of Glioma by Multiparametric Magnetic Resonance Imaging.
Acad Radiol. [2020 May 14]. 2020;S1076-6332(20)30181-1. Doi 10.1016/j.acra.2020.03.035. _




Zaragori T, Ginet M, Marie PY, Roch V, Grignon R, Gauchotte G, Rech F, Blonski M, Lamiral Z, Taillandier L, Imbert L, Verger A.
Use of static and dynamic [18F]-F-DOPA PET parameters for detecting patients with glioma recurrence or progression.
EJNMMI Res. 2020 May 29. 2020;10(1):56. Doi 10.1186/s13550-020-00645-x. _




Zhou X, Niu X, Sun K, Li J, Mao Q, Liu Y.
Pediatric Glioma Outcomes: Predictors of Early Mortality.
World Neurosurg. [2020 May 7]. 2020;S1878-8750(20)30814-7. Doi 10.1016/j.wneu.2020.04.107. _



HIGH-GRADE GLIOMAS



Ahn S, Han KD, Park YM, Bae JM, Kim SU, Jeun SS, Yang SH.
Cigarette Smoking Is Associated with Increased Risk of Malignant Gliomas: A Nationwide Population-Based Cohort Study.
Cancers (Basel). 2020 May 25. 2020;12(5):E1343. Doi 10.3390/cancers12051343. _




Alan O, Telli TA, Tuylu TB, Arikan R, Demircan NC, Ercelep O, Kaya S, Babacan NA, Atasoy BM, Bozkurt S, Bayri Y, Gul D, Ekinci G, Ziyal I, Dane F, Yumuk PF.
Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience.
J Oncol Pharm Pract. [2020 Apr 29]. 2020;1078155220920684. Doi 10.1177/1078155220920684. _




Bergman D, Modh A, Schultz L, Snyder J, Mikkelsen T, Shah M, Ryu S, Siddiqui MS, Walbert T.
Randomized prospective trial of fractionated stereotactic radiosurgery with chemotherapy versus chemotherapy alone for bevacizumab-resistant high-grade glioma.
J Neurooncol. [2020 May 22]. 2020;10.1007/s11060-020-03526-4. Doi 10.1007/s11060-020-03526-4. _




Lan TL, Chou FI, Lin KH, Pan PS, Lee JC, Huang WS, Liu YM, Chao Y, Chen YW.
Using salvage Boron Neutron Capture Therapy (BNCT) for recurrent malignant brain tumors in Taiwan.
Appl Radiat Isot. [2020 Feb 27]. 2020;160:109105. Doi 10.1016/j.apradiso.2020.109105. _




Mistry AM, Mummareddy N, CreveCoeur TS, Lillard JC, Vaughn BN, Gallant JN, Hale AT, Griffin N, Wellons JC, Limbrick DD, Klimo P, Naftel RP.
Association between supratentorial pediatric high-grade gliomas involved with the subventricular zone and decreased survival: a multi-institutional retrospective study.
J Neurosurg Pediatr. [2020 May 22]. 2020;1-7. Doi 10.3171/2020.3.PEDS19593.. _




Reardon DA, Desjardins A, Rixe O, Cloughesy T, Alekar S, Williams JH, Li R, Taylor CT, Lassman AB.
A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma.
Invest New Drugs. [2020 May 20]. 2020;10.1007/s10637-020-00950-1. Doi 10.1007/s10637-020-00950-1. _



LOW-GRADE GLIOMAS



Wu F, Wang ZL, Wang KY, Li GZ, Chai RC, Liu YQ, Jiang HY, Zhai Y, Feng YM, Zhao Z, Zhang W.
Classification of diffuse lower-grade glioma based on immunological profiling.
Mol Oncol. [2020 May 11]. 2020;10.1002/1878-0261.12707. Doi 10.1002/1878-0261.12707. _




Wu F, Li GZ, Liu HJ, Zhao Z, Chai RC, Liu YQ, Jiang HY, Zhai Y, Feng YM, Li RP, Zhang W.
Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma.
J Pathol. [2020 May 17]. 2020;10.1002/path.5468. Doi 10.1002/path.5468. _




Zhao K, Sun G, Wang Q, Xue Z, Liu G, Xia Y, Yao A, Zhao Y, You N, Yang C, Xu B.
The Diagnostic Value of Conventional MRI and CT Features in the Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO Grade II Gliomas.
Acad Radiol. [2020 Apr 28]. 2020;S1076-6332(20)30149-5. Doi 10.1016/j.acra.2020.03.008. _




Zhao L, Zhang J, Liu Z, Zhao P.
Identification of biomarkers for the transition from low-grade glioma to secondary glioblastoma by an integrated bioinformatic analysis.
Am J Transl Res. 2020 Apr 15. 2020;12(4):1222-1238. Issn 1943-8141/AJTR0101960. _



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS


Brendle C, Klose U, Hempel JM, Schittenhelm J, Skardelly M, Tabatabai G, Ernemann U, Bender B.
Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes.
Neurol Sci. [2020 May 28]. 2020;10.1007/s10072-020-04474-7. Doi 10.1007/s10072-020-04474-7. _



GLIOBLASTOMA



Adaku N, Park HB, Spakowicz DJ, Tiwari MK, Strobel SA, Crawford JM, Rogers FA.
A DNA Repair Inhibitor Isolated from an Ecuadorian Fungal Endophyte Exhibits Synthetic Lethality in PTEN-Deficient Glioblastoma.
J Nat Prod. [2020 May 14]. 2020;10.1021/acs.jnatprod.0c00012. Doi 10.1021/acs.jnatprod.0c00012. _



*

Bergmann N, Delbridge C, Gempt J, Feuchtinger A, Walch A, Schirmer L, Bunk W, Aschenbrenner T, Liesche-Starnecker F, Schlegel J.
The Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of Glioblastoma Multiforme: A Regional Immunohistochemistry Analysis.
Front Oncol. 2020 Apr 24. 2020;10:494. Doi 10.3389/fonc.2020.00494. _




Bokstein F, Blumenthal D, Limon D, Harosh CB, Ram Z, Grossman R.
Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study.
Front Oncol. 2020 Apr 21. 2020;10:411. Doi 10.3389/fonc.2020.00411. _




Carminucci A, Tejero R, Huang Y, Danish S, Friedel RH, Foty R.
Teaching an Old Drug New Tricks: Dexamethasone as an In Vivo Inhibitor of Glioblastoma Dispersal.
Cureus. 2020 Apr 20. 2020;12(4):e7749. Doi 10.7759/cureus.7749. _




Choi Y, Nam Y, Lee YS, Kim J, Ahn KJ, Jang J, Shin NY, Kim BS, Jeon SS.
IDH1 mutation prediction using MR-based radiomics in glioblastoma: comparison between manual and fully automated deep learning-based approach of tumor segmentation.
Eur J Radiol. [2020 Apr 30]. 2020;128:109031. Doi 10.1016/j.ejrad.2020.109031. _




Di L, Heath RN, Shah AH, Sanjurjo AD, Eichberg DG, Luther EM, de la Fuente MI, Komotar RJ, Ivan ME.
Resection versus biopsy in the treatment of multifocal glioblastoma: a weighted survival analysis.
J Neurooncol. [2020 May 11]. 2020;10.1007/s11060-020-03508-6. Doi 10.1007/s11060-020-03508-6. _




Dono A, Wang E, Lopez-Rivera V, Ramesh AV, Tandon N, Ballester LY, Esquenazi Y.
Molecular characteristics and clinical features of multifocal glioblastoma.
J Neurooncol. [2020 May 21]. 2020;10.1007/s11060-020-03539-z. Doi 10.1007/s11060-020-03539-z. _




Fukai J, Arita H, Umehara T, Yoshioka E, Shofuda T, Kanematsu D, Kodama Y, Mano M, Kinoshita M, Okita Y, Nonaka M, Uda T, Tsuyuguchi N, Sakamoto D, Uematsu Y, Nakao N, Mori K, Kanemura Y.
Molecular characteristics and clinical outcomes of elderly patients with IDH-wildtype glioblastomas: comparative study of older and younger cases in Kansai Network cohort.
Brain Tumor Pathol. [2020 May 2]. 2020;37(2):50-59. Doi 10.1007/s10014-020-00363-1. _




Gawley M, Almond L, Daniel S, Lastakchi S, Kaur S, Detta A, Cruickshank G, Miller R, Hingtgen S, Sheets K, McConville C.
Development and in vivo evaluation of Irinotecan-loaded Drug Eluting Seeds (iDES) for the localised treatment of recurrent glioblastoma multiforme.
J Control Release. [2020 May 11]. 2020;324:1-16. Doi 10.1016/j.jconrel.2020.05.012. _




Gupta K, Vuckovic I, Zhang S, Xiong Y, Carlson BL, Jacobs J, Olson I, Petterson XM, Macura SI, Sarkaria J, Burns TC.
Radiation Induced Metabolic Alterations Associate With Tumor Aggressiveness and Poor Outcome in Glioblastoma.
Front Oncol. 2020 May 5. 2020;10:535. Doi 10.3389/fonc.2020.00535. _




Kim MS, Lim J, Shin HS, Cho KG.
Re-Irradiation and Its Contribution to Good Prognosis in Recurrent Glioblastoma Patients.
Brain Tumor Res Treat. 2020 Apr 30. 2020;8(1):29-35. Doi 10.14791/btrt.2020.8.e10. _




Miyake JA, Gomes RN, Colquhoun A.
Gamma-linolenic acid alters migration, proliferation and apoptosis in human and rat glioblastoma cells.
Prostaglandins Other Lipid Mediat. [2020 May 18]. 2020:106452. Doi 10.1016/j.prostaglandins.2020.106452. _




Mandonnet E, Margulies D, Stengel C, Dali M, Rheault F, Toba MN, Bonnetblanc F, Valero-Cabre A.
"I do not feel my hand where I see it": causal mapping of visuo-proprioceptive integration network in a surgical glioma patient.
Acta Neurochir (Wien). [2020 May 13]. 2020;10.1007/s00701-020-04399-2. Doi 10.1007/s00701-020-04399-2. _




Muftuoglu Y, Liau LM.
Results From the CheckMate 143 Clinical Trial: Stalemate or New Game Strategy for Glioblastoma Immunotherapy?
JAMA Oncol. [2020 May 21]. 2020;10.1001/jamaoncol.2020.0857. Doi 10.1001/jamaoncol.2020.0857. _
Referring to: Reardon DA, et al.,Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial. JAMA Oncol. [2020 May 21]. 2020;e201024. Doi 10.1001/jamaoncol.2020.1024. _




Orzan F, Pagani F, Cominelli M, Triggiani L, Calza S, De Bacco F, Medicina D, Balzarini P, Panciani PP, Liserre R, Buglione M, Fontanella MM, Medico E, Galli R, Isella C, Boccaccio C, Poliani PL; on behalf of the Neuro-Oncology group of Spedali Civili of Brescia.
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes.
Lab Invest. [2020 May 13]. 2020;10.1038/s41374-020-0437-0. Doi 10.1038/s41374-020-0437-0. _




Rahman R, Trippa L, Alden S, Fell G, Abbasi T, Mundkur Y, Singh NK, Talawdekar A, Husain Z, Vali S, Ligon KL, Wen PY, Alexander BM.
Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide.
Int J Radiat Oncol Biol Phys. [2020 May 14]. 2020:S0360-3016(20)31134-2. Doi 10.1016/j.ijrobp.2020.05.010. _




Rajesh Y, Biswas A, Kumar U, Banerjee I, Das S, Maji S, Das SK, Emdad L, Cavenee WK, Mandal M, Fisher PB.
Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma.
Proc Natl Acad Sci U S A. [2020 May 14]. 2020;117(22):12324-12331. Doi 10.1073/pnas.1921531117. _




Ramakrishnan MS, Vora RA, Gilbert AL.
Glioblastoma multiforme mimicking optic neuritis.
Am J Ophthalmol Case Rep. [2020 Jan 7]. 2020;17:100594. Doi 10.1016/j.ajoc.2020.100594. _




Reardon DA, Brandes AA, Omuro A, Mulholland P, Lim M, Wick A, Baehring J, Ahluwalia MS, Roth P, Bähr O, Phuphanich S, Sepulveda JM, De Souza P, Sahebjam S, Carleton M, Tatsuoka K, Taitt C, Zwirtes R, Sampson J, Weller M.
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.
JAMA Oncol. [2020 May 21]. 2020;e201024. Doi 10.1001/jamaoncol.2020.1024. _




Rijnen SJM, Butterbrod E, Rutten GM, Sitskoorn MM, Gehring K.
Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up.
Neurosurgery. [2020 May 29]. 2020;nyaa190. Doi 10.1093/neuros/nyaa190. _




Sabour S.
Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy; Methodological issues to avoid misinterpretation.
Magn Reson Imaging. [2020 May 16]. 2020;71:25-26. Doi 10.1016/j.mri.2020.05.005. _
Referring to: Larsson C, et al.,Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy. Magn Reson Imaging. [2020 Jan 28]. 2020;68:106-112. Doi 10.1016/j.mri.2020.01.012. _




Sheehan K, Sheehan D, Sulaiman M, Padilla F, Moore D, Sheehan J, Xu Z.
Investigation of the tumoricidal effects of sonodynamic therapy in malignant glioblastoma brain tumors.
J Neurooncol. [2020 May 2]. 2020;148(1):9-16. Doi 10.1007/s11060-020-03504-w. _




Shieh LT, Guo HR, Ho CH, Lin LC, Chang CH, Ho SY.
Survival of glioblastoma treated with a moderately escalated radiation dose-Results of a retrospective analysis.
PLoS One. 2020 May 15. 2020;15(5):e0233188. Doi 10.1371/journal.pone.0233188. _




Saha D, Rabkin SD, Martuza RL.
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma.
J Immunother Cancer. [2020 May 25]. 2020;8(1):e000345. Doi 10.1136/jitc-2019-000345. _




Stein M, Dohmen H, Wölk B, Eberle F, Kolodziej M, Acker T, Uhl E, Jensen A.
Case Report of Complete Radiological Response of a Thalamic Glioblastoma After Treatment With Proton Therapy Followed by Temozolomide and Tumor-Treating Fields.
Front Oncol. 2020 Apr 21. 2020;10:477. Doi 10.3389/fonc.2020.00477. _




Stragliotto G, Pantalone MR, Rahbar A, Bartek J, Söderberg-Nauclér C.
Valganciclovir as add-on to standard therapy in glioblastoma patients.
Clin Cancer Res. [2020 May 18]. 2020;clincanres.0369.2020. Doi 10.1158/1078-0432.CCR-20-0369. _




Wang Z, Liu F, Liao W, Yu L, Hu Z, Li M, Xia H.
Curcumin suppress glioblastoma cell proliferation by p-AKT/mTOR pathway and increased the PTEN expression.
Arch Biochem Biophys. [2020 May 21]. 2020;108412. Doi 10.1016/j.abb.2020.108412. _




Wee CW, Kim IH, Park CK, Kim N, Suh CO, Chang JH, Lim DH, Nam DH, Kim IA, Kim CY, Oh YT, Chung WK, Kim SH.
Chemoradiation in elderly patients with glioblastoma from the multi-institutional GBM-molRPA cohort: is short-course radiotherapy enough or is it a matter of selection?
J Neurooncol. [2020 May 2]. 2020;148(1):57-65. Doi 10.1007/s11060-020-03468-x. _
Erratum in: J Neurooncol. 2020 May 12. 2020;148(1):67. Doi 10.1007/s11060-020-03532-6. _




Whitmire P, Rickertsen CR, Hawkins-Daarud A, Carrasco E Jr, Lorence J, De Leon G, Curtin L, Bayless S, Clark-Swanson K, Peeri NC, Corpuz C, Lewis-de Los Angeles CP, Bendok BR, Gonzalez-Cuyar L, Vora S, Mrugala MM, Hu LS, Wang L, Porter A, Kumthekar P, Johnston SK, Egan KM, Gatenby R, Canoll P, Rubin JB, Swanson KR.
Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients.
BMC Cancer. 2020 May 19. 2020;20(1):447. Doi 10.1186/s12885-020-06816-2. _




Zhou X, Niu X, Mao Q, Liu Y.
Clinical Significance of Various Classification Standards of Age Groups in Predicting Survival of Patients with Glioblastoma.
Med Sci Monit. [2020 Mar 31]. 2020;26:e920627. Doi 10.12659/MSM.920627. _



GLIOSARCOMA



Choi MG, Lee JH, Lee MS, Suh SJ, Lee YS, Kang DG.
Primary Gliosarcoma with Extracranial Metastasis.
Brain Tumor Res Treat. 2020 Apr 30. 2020;8(1):53-56. Doi 10.14791/btrt.2020.8.e9. _



EPITHELIOID GLIOBLASTOMA



Zeng Y, Zhu X, Wang Y, Liu B, Yang X, Wang Q, Du J, Ma Y, Lin L, Fu P, Xiao H, Guo QN.
Clinicopathological, Immunohistochemical and Molecular Genetic Study on Epithelioid Glioblastoma: A Series of Fifteen Cases with Literature Review.
Onco Targets Ther. 2020 May 8. 2020;13:3943-3952. Doi 10.2147/OTT.S249317. _



DIFFUSE MIDLINE GLIOMA



Ensan D, Smil D, Zepeda-Velázquez CA, Panagopoulos D, Wong JF, Williams EP, Adamson R, Bullock AN, Kiyota T, Aman A, Roberts OG, Edwards AM, O'Meara JA, Isaac MB, Al-Awar R.
Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma.
J Med Chem. [2020 May 5]. 2020;63(9):4978-4996. doi: 10.1021/acs.jmedchem.0c00395. _




Jaimes C, Vajapeyam S, Brown D, Kao PC, Ma C, Greenspan L, Gupta N, Goumnerova L, Bandopahayay P, Dubois F, Greenwald NF, Zack T, Shapira O, Beroukhim R, Ligon KL, Chi S, Kieran MW, Wright KD, Poussaint TY.
MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma.
AJNR Am J Neuroradiol. 2020 May 1. 2020;41(5):874-881. Doi 10.3174/ajnr.A6546. _




Mosaab A, El-Ayadi M, Khorshed EN, Amer N, Refaat A, El-Beltagy M, Hassan Z, Soror SH, Zaghloul MS, El-Naggar S.
Histone H3K27M Mutation Overrides Histological Grading in Pediatric Gliomas.
Sci Rep. 2020 May 20. 2020;10(1):8368. 2020;10:8368. Doi 10.1038/s41598-020-65272-x. _




Van Gool SW, Makalowski J, Bonner ER, Feyen O, Domogalla MP, Prix L, Schirrmacher V, Nazarian J, Stuecker W.
Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience.
Medicines (Basel). 2020 May 19. 2020;7(5):E29. Doi 10.3390/medicines7050029. _




Wongthida P, Schuelke MR, Driscoll CB, Kottke T, Thompson JM, Tonne J, Stone C, Huff AL, Wetmore C, Davies JA, Parker AL, Evgin L, Vile RG.
Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors.
Neuro Oncol. [2020 May 27]. 2020;noaa126. Doi 10.1093/neuonc/noaa126. _




Zhang L, Yu H, Xue Y, Liu Y.
Decreased natural killer cells in diffuse intrinsic pontine glioma patients.
Childs Nerv Syst. [2020 May 16]. Doi 10.1007/s00381-020-04665-9. _



EPENDYMAL TUMORS



EPENDYMOMA



Alkhaibary A, AlSufiani F, Alassiri AH, Almuntashri M, Al Qutub ST.
Chondro-Osseous Metaplasia in Ependymoma: A Rare Histopathological Finding.
Case Rep Pathol. 2020 May 5. 2020;2020:1528698. Doi 10.1155/2020/1528698. _



TUMORS OF THE PINEAL REGION



PYNEOCITOMA



Almahariq F, Raguz M, Romic D, Dlaka D, Oreskovic D, Sesar P, Chudy D.
A biphasic tumor in posterior cranial fossa and the pineal region in young adult.
Surg Neurol Int. 2020 Apr 11. 2020;11:64. Doi 10.25259/SNI_288_2019. _



EMBRYONAL TUMORS



MEDULLOBLASTOMA



Dirven L, Luerding R, Beier D, Bumes E, Reinert C, Seidel C, Bonsanto MM, Bremer M, Rieken S, Combs SE, Herrlinger U, Seliger C, Kuntze H, Mayer-Steinacker R, Dieing A, Bartels C, Schnell O, Weyerbrock A, Seidel S, Grauer O, Nadji-Ohl M, Paulsen F, Weller M, Wick W, Hau P.
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study.
J Neurooncol. [2020 May 4]. 2020;148(1):117-130. Doi 10.1007/s11060-020-03502-y. _




Reichl B, Niederstaetter L, Boegl T, Neuditschko B, Bileck A, Gojo J, Buchberger W, Peyrl A, Gerner C.
Determination of a Tumor-Promoting Microenvironment in Recurrent Medulloblastoma: A Multi-Omics Study of Cerebrospinal Fluid.
Cancers (Basel). 2020 May 26. 2020;12(6):E1350. Doi 10.3390/cancers12061350. _




Robinson GW, Gajjar A.
Genomics Paves the Way for Better Infant Medulloblastoma Therapy.
J Clin Oncol. [2020 Apr 30]. 2020;JCO2000593. Doi 10.1200/JCO.20.00593. _
Referring to: Mynarek M, et al., Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort. J Clin Oncol. [2020 Apr 24]. 2020;JCO1903057. Doi 10.1200/JCO.19.03057. _




Visani M, Marucci G, Biase D, Giangaspero F, Buttarelli FR, Brandes AA, Franceschi E, Acquaviva G, Ciarrocchi A, Rhoden KJ, Tallini G, Pession A.
miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children.
Diagnostics (Basel). 2020 Apr 29. 2020;10(5):E265. Doi 10.3390/diagnostics10050265. _



ATYPICAL THERATOID/RHABDOID TUMOR



Jangra A, Choi SA, Yang J, Koh EJ, Phi JH, Lee JY, Wang KC, Kim SK.
Disulfiram potentiates the anticancer effect of cisplatin in atypical teratoid/rhabdoid tumors (AT/RT).
Cancer Lett. [2020 May 16]. 2020;486:38-45. Doi 10.1016/j.canlet.2020.05.006. _



MENINGIOMAS



MENINGIOMA



Suradom C, Suttajit S, Soontornpun A, Pinyopornpanish M.
Frontal lobe meningioma presenting with schizophrenia-like symptoms: an organic cause of psychotic disorder.
BMJ Case Rep. 2020 Apr 28. 2020;13(4):e234526. Doi 10.1136/bcr-2020-234526. _



MESENCHIMAL NON-MENINGOTHELIAL TUMORS


Takamori S, Seto T, Jinnouchi M, Matsubara T, Haratake N, Miura N, Toyozawa R, Yamaguchi M, Takenoyama M.
Brain cavernous hemangioma mimicking radiation-induced necrosis in a patient with non-small cell lung cancer.
Thorac Cancer. [2020 May 29]. 2020;10.1111/1759-7714.13494. Doi 10.1111/1759-7714.13494. _



METASTATIC TUMORS


Chu C, Davis CM, Lan X, Hienz RD, Jablonska A, Thomas AM, Velarde E, Li S, Janowski M, Kai M, Walczak P.
Neuroinflammation following stereotactic radiosurgery-induced brain tumor disintegration is linked to persistent cognitive decline in a mouse model of metastatic disease.
Int J Radiat Oncol Biol Phys. [2020 May 25]. 2020;S0360-3016(20)31151-2. Doi 10.1016/j.ijrobp.2020.05.027. _.



bottom